Multifaceted role of cardiovascular biomarkers
Related Experiment Video
Updated: Aug 11, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
1Department of Cardiovascular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01655, USA.
Insights
Cardiovascular disease (CVD) biomarkers aid early detection and prevention. Novel, non-invasive biomarkers improve diagnosis and risk assessment, including for COVID-19 patients.
Area of Science:
- Biochemistry
- Cardiology
- Medical Diagnostics
Background:
- Cardiovascular diseases (CVDs) are a leading global health concern.
- Late-stage diagnosis often necessitates heart transplantation.
- Early detection through risk identification and preventive measures is crucial.
Purpose of the Study:
- To review various categories of cardiovascular biomarkers.
- To emphasize novel biomarkers for CVD diagnosis and prognosis.
- To discuss the utility of biomarkers in identifying cardiovascular complications in COVID-19 patients.
Main Methods:
- Literature review of cardiovascular biomarker research.
- Categorization of existing and novel biomarkers.
- Analysis of biomarker applications in CVD and COVID-19.
Main Results:
- Biomarkers are critical for early CVD diagnosis and risk stratification.
- Recent discoveries include more specific and sensitive biomarkers.
- Non-invasive biomarkers offer an advantage for assessing pathophysiological status.
Conclusions:
- Biomarkers are essential tools for managing cardiovascular diseases.
- Novel biomarkers enhance diagnostic accuracy and prognostic capabilities.
- Biomarkers play a role in identifying high-risk COVID-19 patients for cardiovascular complications.
Abstract:
Cardiovascular diseases, a global health issue, claim the lives of many every year. Lifestyle changes and genetic predisposition are the key drivers for the development of CVDs. In many of the patients, the disease is detected at the end stage making heart transplantation the only treatment option. Hence every attempt should be made to identify the risk at an early stage and initiate preventive measures to improve the quality of their life. Biomarkers are one of the critical factors that aid in the early diagnosis of CVDs. More specific and highly sensitive biomarkers have been discovered lately and have been employed for prognosis and diagnosis of CVDs. The present review briefs about the various categories of cardiovascular biomarkers with emphasis on novel biomarkers and discusses the biomarkers employed for different purposes in CVDs. The biomarkers have also helped in identifying COVID-19 patients with increased risk for developing cardiovascular complications. Being non-invasive makes biomarkers advantageous over other methods for evaluating the pathophysiological status of CVDs.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction
Cardiovascular Drugs: Classification based on Therapeutic Indications
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Pathophysiology of Cardiac Performance

